Cargando…

Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx

INTRODUCTION: ADAM33 protein is a member of the family of transmembrane glycoproteins composed of multidomains. Members of the ADAM family have different activities, such as proteolysis and adhesion, making them good candidates to mediate the extracellular matrix remodeling and changes in cellular a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stasikowska-Kanicka, Olga, Wągrowska-Danilewicz, Małgorzata, Danilewicz, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754369/
https://www.ncbi.nlm.nih.gov/pubmed/26925122
http://dx.doi.org/10.5114/aoms.2016.57583
_version_ 1782416002649161728
author Stasikowska-Kanicka, Olga
Wągrowska-Danilewicz, Małgorzata
Danilewicz, Marian
author_facet Stasikowska-Kanicka, Olga
Wągrowska-Danilewicz, Małgorzata
Danilewicz, Marian
author_sort Stasikowska-Kanicka, Olga
collection PubMed
description INTRODUCTION: ADAM33 protein is a member of the family of transmembrane glycoproteins composed of multidomains. Members of the ADAM family have different activities, such as proteolysis and adhesion, making them good candidates to mediate the extracellular matrix remodeling and changes in cellular adhesion that characterize certain pathologies and cancer development. MATERIAL AND METHODS: The immunohistochemical method was used to examine the immunoexpression of ADAM33 in 39 formalin-fixed, paraffin-embedded tissue specimens of sinonasal inverted papillomas (IP), 44 laryngeal squamous cell carcinomas (GI grade = 11, GII grade = 33) and 14 disease-free tissue specimens as a control. RESULTS: The immunoexpression of ADAM33 was localized in the epithelial cells, mesenchymal cells of the vessels and infrequently in the stromal cells. The majority of the ADAM33 was localized intracellularly, although membrane immunoexpression was also noted. All epithelial and vascular staining scores were found to be significantly increased in GI and GII grades of laryngeal cancer compared with controls (p < 0.001) and IP (p < 0.001). No statistically significant differences were found in immunoexpression of ADAM33 between GI and GII tumors. The immunoexpression of ADAM33 was significantly higher in IP patients than in controls (p < 0.02). CONCLUSIONS: Our findings suggest that ADAM33 could potentially contribute to tumorigenesis of the laryngeal and sinonasal region.
format Online
Article
Text
id pubmed-4754369
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-47543692016-02-26 Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx Stasikowska-Kanicka, Olga Wągrowska-Danilewicz, Małgorzata Danilewicz, Marian Arch Med Sci Clinical Research INTRODUCTION: ADAM33 protein is a member of the family of transmembrane glycoproteins composed of multidomains. Members of the ADAM family have different activities, such as proteolysis and adhesion, making them good candidates to mediate the extracellular matrix remodeling and changes in cellular adhesion that characterize certain pathologies and cancer development. MATERIAL AND METHODS: The immunohistochemical method was used to examine the immunoexpression of ADAM33 in 39 formalin-fixed, paraffin-embedded tissue specimens of sinonasal inverted papillomas (IP), 44 laryngeal squamous cell carcinomas (GI grade = 11, GII grade = 33) and 14 disease-free tissue specimens as a control. RESULTS: The immunoexpression of ADAM33 was localized in the epithelial cells, mesenchymal cells of the vessels and infrequently in the stromal cells. The majority of the ADAM33 was localized intracellularly, although membrane immunoexpression was also noted. All epithelial and vascular staining scores were found to be significantly increased in GI and GII grades of laryngeal cancer compared with controls (p < 0.001) and IP (p < 0.001). No statistically significant differences were found in immunoexpression of ADAM33 between GI and GII tumors. The immunoexpression of ADAM33 was significantly higher in IP patients than in controls (p < 0.02). CONCLUSIONS: Our findings suggest that ADAM33 could potentially contribute to tumorigenesis of the laryngeal and sinonasal region. Termedia Publishing House 2016-02-02 2016-02-01 /pmc/articles/PMC4754369/ /pubmed/26925122 http://dx.doi.org/10.5114/aoms.2016.57583 Text en Copyright © 2016 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Research
Stasikowska-Kanicka, Olga
Wągrowska-Danilewicz, Małgorzata
Danilewicz, Marian
Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
title Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
title_full Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
title_fullStr Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
title_full_unstemmed Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
title_short Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
title_sort immunohistochemical study on adam33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754369/
https://www.ncbi.nlm.nih.gov/pubmed/26925122
http://dx.doi.org/10.5114/aoms.2016.57583
work_keys_str_mv AT stasikowskakanickaolga immunohistochemicalstudyonadam33insinonasalinvertedpapillomasandsquamouscellcarcinomasofthelarynx
AT wagrowskadanilewiczmałgorzata immunohistochemicalstudyonadam33insinonasalinvertedpapillomasandsquamouscellcarcinomasofthelarynx
AT danilewiczmarian immunohistochemicalstudyonadam33insinonasalinvertedpapillomasandsquamouscellcarcinomasofthelarynx